Janssen (JNJ), Bayer Announces VENTURE-AF Results; Major Bleeds Were Minimal
Tweet Send to a Friend
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, announced results from the VENTURE-AF trial. The study explored the potential ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
